Quanterix Financial Results Q1 2026
Quanterix Corporation announced its financial results for the first quarter of 2026, indicating progress towards cash flow breakeven and growth following the acquisition of Akoya. CEO Everett Cunningham highlighted the achievement of cost synergies from the acquisition, confirming a positive outlook for the company’s performance.
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the first quarter ended March 31, 2026. “We continue to make progress toward achieving cash flow breakeven as we move into a phase of growth now that we have captured the cost synergies from the Akoya acquisition,” said Everett Cunningham, President & CEO of Quanterix. “As part